Tirzepatide deep-dive Tirzepatide is made by Eli Lilly under two brand names: Mounjaro -- weekly injection, FDA-approved for type 2 diabetes in 2022 (doses 2.5 mg through 15 mg) Zepbound -- weekly injection, FDA-approved for chronic weight management in November 2023 [4] The headline trial is SURMOUNT-1: 2,539 adults without diabetes, BMI of 30 or higher (or 27 with a weight-related condition), randomized across three tirzepatide doses (5, 10, 15 mg) versus placebo for 72 weeks
Tirzepatide activates both GLP-1 and GIP receptors, recruiting additional metabolic pathways that semaglutide alone does not engage
Whether youre actively planning pregnancy, want to keep your options open for the future, or need to prevent pregnancy while pursuing weight loss goals, understanding how Ozempic affects these considerations helps you make decisions aligned with your health priorities and family planning goals
For patients with obesity or mainly seeking a weight loss injection, Wegovy is the only one approved by the FDA, while Ozempic and Rybelsus are focused more on blood sugar control
For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals
Board-Certified Dr
